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approximately 10% are eligible to undergo a radical surgical operation (1, 2) . Any adenocarcinoma of the pancreas is the most common malignancy of the pancreas and the pancreatoduodenal area, and this area is a site of origin of many proliferative lesions of various, often not definitely established, malignant potential. Surgical treatment is the only effective management of any tumor of this area, however surgical approach and prognosis differ markedly depending on histological type of the tumor.
Aim of the study was to characterize tumors of the pancreas and the pancreatoduodenal area in our own material as well as early results of surgical treatment including complications.
MATERIAL AND METHODS
Since March 2005, a systematic prospective assessment was started that involved patients with tumors of the pancreas that underwent surgical treatment in Department of Surgery, Clinic of Oncology, Center of Oncology in Warszawa. A specific case report form that included the following endpoints: early survival, late survival and complications of surgical treatment, was prepared for each patient besides standard medical records.
Vast majority of patients were referred for surgical treatment after previous complete diagnostic examinations that they had undergone in departments of internal medicine and gastrology. 85 patients (42 women, 43 men) with lesion of the pancreas or ampulla of Vater potentially amenable to surgical resection, were qualified for the surgical treatment between 1.03.2005 and 31.12.2006 (22 months). Due to specific design of our center, when physical examination and imaging examinations indicated nonoperative lesion and patients required palliative surgery, they were referred to other departments of surgery.
An average age of patients undergoing surgery was 62.1 years (SD 10.5, range 28-83 years).
All patients underwent the surgical procedure under general anesthesia. Conventionally a transverse section was performed below costal arches. Antithrombotic prophylaxis with low molecular weight heparins according to current regimen was used in all patients. 2 nd generation cephalosporin combined with metronidazole were used as perioperative prophylaxis.
Oral nutrition was introduced 5-6 days after the surgery in patients after uncomplicated palliative and radical procedures. Complete parenteral nutrition was introduced in any patient at risk of complications of resective procedures.
Computed tomography, most often preceded by ultrasound of the abdominal cavity, were the basic imaging studies in all patients. Additional tests included also endoscopic examinations, endosonographic examinations, magnetic resonance imaging. Presence of malignant cells was confirmed in 7 patients with preoperative EUS guided endoscopic fine needle biopsy, including 2 patients in whom probable neuroendocrine tumor was detected.
Tumors of the head of the pancreas (43.53%) and the body of the pancreas (28.23%) were the most common preoperative diagnoses. Table 1 presents detailed characteristics of preoperative diagnoses.
RESULTS

Resective operations
Forty three patients among operated subjects underwent a resective operation. Pancreatoduodenectomy (performed in 17 patients, 39.5% of resective operations) was the most common procedure in the presented material. 5 patients underwent a conventional Whipple operation and 12 patients underwent a procedure with pylorus sparing. The residual pancreas was anastomosed in a posterior wall of the stomach in 14 patients and in a segment of the jejunum in the remaining 3 patients. The choice of anastomosis of the residual pancreas was dictated by the clinical situation and preferences of an operator. In 7 patients undergoing the surgery (16.3% of resective operations), in whom macroscopic changes of the pancreas resembled that in chronic pancreatitis, total resection of the pancreas was performed. Peripheral splenopancreatectomy was performed when lesions were located in the tail of the pancreas and at the border of the body and the tail of the pancreas -16 patients (7.2% resective operations).
In 3 patients (7% of resective operations) with preoperative diagnosis of neuroendocrine tumor, a decision was taken to perform a local excision of the lesion.
Characteristics of performed resective operations is presented in tab. 2.
Palliative operations
Intraoperatively it was established that resective operation could not be performed in 42 out of 85 patients (49.4%). In such event a decision was taken to perform an operation adjusted to current clinical situation, to improve patient's quality of life. The most common operations in this group of patients included laparotomy with taking samples and neurolysis of splanchnic plexus and by-pass anastomosis of duodenum and biliary tract -15 patients each. This group included also 3 patients with cysts of the pancreas in whom drainage operations were performed (tab. 3).
The most common reason for the lesion unresectability was invasion of the mesenteric vessels -in 12 out of 42 patients (28.6%). Only massive involvement of the mesenteric artery or vein led to disqualification from an operation. In two patients from the radical operation group who had a small involvement of the superior mesenteric vein, partial resection of the vein wall along with the infiltrating tumor was performed with primary vessel reconstruction. No complications related to such management were observed in such patients. The second most common reason for the lesion unresectability were metastases in the liver and involvement of portal vein confluence that occurred in 8 (19%) patients each. In six cases (14.3%) an operator decided that local advancement of the lesion, which mainly meant solid and immobile infiltration extending to the extraperitoneal space, made radical management impossible. In 3 (7%) patients disseminated abdominal metastases were detected. One patient developed hemodynamic disturbances several minutes after the start of the surgical procedure which required urgent termination of the procedure. Gastric retention was defined as requirement for prolonged maintenance of nasogastric tube, for over 3 days, with the volume of drained contents exceeding 500 ml daily. One patient developed superficial infection of the surgical site manifesting as a wound infection. One patient with subphrenic abscess after pancreatoduodenectomy, was successfully treated with US-guided percutaneous drainage. One patient developed upper gastrointestinal bleeding which was treated medically. 9 patients (10.59%) had to be reoperated. 2 patients (2.76%) from the palliative operation group were reoperated -a 64-year old woman on day 7 after by-pass anastomoses and neurolysis, was found to have a bleeding into the peritoneal cavity; planar bleeding at the site of Kocher maneuver was found and hemostasis was done. The patient was discharged home on day 13 after the first operation. Another patient, 69-year old man, required surgical drainage of an intrahepatic abscess on day 5 after gastrojejunostomy; further course of his hospitalization was uncomplicated and he was discharged home on day 13 after the primary operation.
7 patients (16.28%) required reoperation in the group of patients after a radical operation, Male age 68 on day 6 after PPPD dehiscence of pancreatogastrostomy peripheral splenopancreatectomy was performed discharge on day 18 after the primary operation Male age 33 on day 12 after peripheral splenopancreatectomy intraperitoneal abscess suspected relaparotomy without purulent collections discharge on day 21 after the primary operation Male age 42 after Whipple operation 4. deventration suturing abdominal wall, day 9 dehiscence of pancreatic and biliary anastomoses, day 15 leakage of biliary contents relaparotomy and peritoneal washing, day 30 interloop abscesses washing + drainage, day 47 repeated interloop abscesses washing drainage discharged on day 95 after the primary operation Female age 48 local lesion resection discharged on day 8, readmitted on day 14 with necrosis of the tail of the pancreas peripheral splenopancreatectomy was performed discharged on day 7 after the operation Male age 56 after PPPD on day 10 inflammation of the remaining pancreas T necrectomy, discharge on day 17 after the primary operation Female age 62 after PPPD on day 7 partial dehiscence of pancreatogestrostomy -relaparotomy + drainage, dischage on day 21 after the primary operation Female age 66 after Whipple pancreatoduodenectomy, on day 6 after the operation bleeding from the remaining pancreatic tissue to gastrointestinal tract and peritoneum reoperated underpinning of the bleeding vessel, on day 12 necrosis of the remaining pancreatic tissue relaparotomy, resection of the remaining pancreas, on day 20 subphrenic abscess relaparotomy and drainage, death on day 31 in ICU including 5 (20.83%) patients after pancreatoduodenectomies, 2 (8.33%) of which were performed at least twice. Detailed characteristics of complications in this group is presented in tab. 5.
Two (2.35%) deaths were recorded in the presented patient group, including one patient after a palliative operation -1/42 (2.38%) and one after a resective operation -1/43 (2.32%).
A 76-year old man with the tumor of the tail of the pancreas and disseminated malignancy, developed circulatory-respiratory insufficiency and died on day 17 after Braun gastrojejunostomy.
A 66-year old women after Whipple pancreatoduodenectomy that underwent several reoperations, died in the radical operation group (tab. 5).
Histopathology
Adenocarcinoma was the predominant postoperative pathological diagnosis -it was found in 33 patients (38.82%). Radical operation was performed only in 13 patients (39.4%) from this group. pT3N0 was the predominant stage in this group (8 patients), followed by pT3N1 (2 patients) while stages pT1N0, pT2N0, pT2N1 were found only in one patient each. Chronic pancreatitis was the second most common pathological diagnosis (14.12%). As a comparison, pancreatoduodenectomy was performed in all 7 patients with carcinoma of the ampulla of Vater.
In 8 (9.4%) cases histopathological diagnosis did not confirm malignant origin of the lesion. This was the case when e.g. clinical diagnosis was a tumor of the pancreas and the result of histopathological examination ruled out malignancy and concurrently not unequivocally confirmed chronic pancreatitis. Such situation also occurred when the patient had a malignancy but the sample taken by an operator was misrepresentative and did not contain malignant tissue or when a patient had no malignancy, what was indicated by postoperative observation.
No lesion samples were taken when intraoperatively the lesion was considered unresectable and confirmation of malignancy was obtained before the operation using fine needle biopsy. Complete characteristics of pathological diagnoses is presented in tab. 6.
DISCUSSION
Surgical treatment still remains the only effective management of patients with cancer of the pancreas. In specialist centers, in selected groups of operated patients, 5-year survival is recorded in 10-24% of patients (3, 4) . 5-year survival critically depends on the cancer stage and is 50.3% for stage I, 16.5% for stage II and 5.9% for stage III (5). Whipple pancreatoduedenectomy that for the first time was performed and described by Whipple (6) , in one of its variations, remains still the basic method of treatment of tumors of the pancreas and the pancreatoduodenal area.
Currently there is no unequivocal definition of pancreatic cancer amenable to surgical resection. It is commonly accepted that tumors that do not involve the superior mesenteric artery, celiac plexus, aorta and the inferior vena cava and with metastases restricted to lymph nodes located in the immediate proximity of the tumor, are considered amenable to surgical resection. R0 resection, i.e. surgical margin free of malignant cells, is an objective of the operation (7).
Until recently malignant involvement of portal vein confluence and portal vein was considered to significantly worsen prognosis (8) . However, in the middle 1990's opinions emerged that portal vein resection with its subsequent reconstruction, with clear surgical margin, was associated with similar treatment outcome as in patients with resection but without involvement of venous vessels (9) .
Currently more and more reports indicate that involvement of the superior mesenteric vein and even portal vein is not considered contraindication to the resection with concomitant reconstruction of the vessels, but there is no agreement on this issue in the literature (10, 11) .
Authors of this study considered massive involvement of the portal vein confluence as a contraindication for resection. Two patients with point involvement of the superior mesenteric vein underwent a marginal resection of the vessel wall; no early or late complications of the procedure were observed. An issue of extensiveness of the lymph node removal in the cancer of the pancreas is still debatable. Japanese authors in particular emphasize feasibility of extensive lymphadenectomies (12) . However, analysis of data from large patient groups has not revealed differences in five year survival following extensive lymphadenectomies versus standard pancreatoduodenectomy (13) .
Currently routine extended lymphadenectomies are done less and less often, because they have no effect on long-term survival while concurrently increase complications rate (14) . In agreement with these data, no operations with extended lymphadenectomy were performed in the presented material.
Thirty years ago, mortality and complications associated with pancreatoduodenectomy were so high that feasibility of resective operations was questioned (15) .
Currently periooperative mortality in resections of the pancreas in specialist centers is below 5% and often is reported to be below 2% (16, 17, 18) . Decrease of mortality is related to improvements to surgical technique as well as to postoperative care. The mortality rate is considered to be the lowest in the specialist centers (performing at least 20 pancreatoduodenectomies annually). In the presented material mortality was 2.32% for all resective operations and 4.17% for pancreatoduodenectomies and thus was comparable to current literature data.
Despite more and more accurate diagnostic modalities, rate of lesions not able (?) to surgical resection remains high. Among patients considered to have a lesion amenable to surgical resection basing on preoperative computed tomography scanning, as high as 30% may be disqualified from the operation intraoperatively (19) . Diagnostic laparoscopy is on of modalities that could decrease the number of unnecessary laparotomies. Currently available data indicate that laparoscopy, as an introduction to an elective operation, may reduce the number of unnecessary laparotomies by over 50% (20) . In the presented material, majority of patients with lesions not amenable to resective therapy, underwent palliative operations. It is debatable whether laparoscopy is an optimal solution when there are contraindications for resection. Perioperative mortality in the group of patients undergoing palliative treatment was 2.38% (one patient). Concurrent performance of by-pass anastomoses and neurolysis of splanchnic trunk markedly improves quality of life of patients with advanced tumor of the pancreas and pancreatoduodenal area not amenable to surgical resection. No differences with respect to number of complications depending on extensiveness of palliative operation have been observed. Complication and mortality rate is similar both after biliary anastomosis and simultaneous gastrojejunal anastomosis (21) .
According to literature data, adenocarcinoma of the pancreas constitutes over 90% of pancreatic tumors, while in the presented material (including only pancreatic tumors) it was below 70%. According to literature, neuroendocrine tumors of the pancreas constitute approximately 5% cases, while this figure was 10% in our study. These discrepancies stem from close cooperation of our department with departments of endocrinology and specific preselection of patients referred to our site.
Operations of the pancreas, pancreatoduodenectomy in particular, still remain procedures with high rate of complications. Current surgical technique allows the leakage rate of biliary-intestinal anastomosis to be around 5% (23) . Pancreatic fistula in the pancreatointestinal or pancreatogastric anatstomosis still remains a significant problem and occurs in approximately 10-20% patients, however currently it rather leads to prolonged hospitalization, while rarely requires reoperation or leads to death (24) .
One of the most common complications of pancreatoduodenectomy is delayed gastric emptying. It is difficult to unequivocally define delayed gastric emptying. Literature descriptions range from nausea and avoidance of oral food intake to persistent vomiting with requirement for maintaining a nasogastric tube for many days. This complication often leads to prolongation of hospitalization. It is reported to have various incidence, up to 20%. Currently this complication is believed to have similar incidence after conventional pancreatoduodenectomy as well as after an operation with sparing of the pylorus (25) . The rate of complications in our study is not significantly different from that reported in the literature.
However, large number of complications after pancreatic operations and pancreatodu-
